Analyst Price Targets — PBH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 30, 2026 5:48 pm | Keith Devas | Jefferies | $66.00 | $64.18 | TheFly | Prestige Consumer price target lowered to $66 from $70 at Jefferies |
| October 27, 2025 11:40 am | — | Jefferies | $71.00 | $61.96 | TheFly | Prestige Consumer price target lowered to $71 from $75 at Jefferies |
| November 5, 2024 12:26 pm | SUsan Anderson | Canaccord Genuity | $86.00 | $74.58 | StreetInsider | Presitge Brands (PBH) PT Raised to $86 at Canaccord Genuity |
| June 21, 2024 6:15 am | Linda Bolton Weiser | D.A. Davidson | $93.00 | $68.13 | StreetInsider | DA Davidson Defending Presitge Brands (PBH), Uprades to Buy |
| November 17, 2022 6:06 am | — | Canaccord Genuity | $71.00 | $58.35 | Benzinga | Canaccord Genuity Initiates Coverage On Prestige Consumer with Buy Rating, Announces Price Target of $71 |
Latest News for PBH
On June 30, 2026, John Rogers (Trades, Portfolio) executed a notable transaction involving Prestige Consumer Healthcare Inc (PBH). The transaction saw an additi
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
TARRYTOWN, N.Y., July 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (“Prestige”) today announced that it has closed the previously announced acquisition of LaCorium Health (“LaCorium”), priced a private offering of $400 million in senior notes, and will report its first quarter fiscal 2027 results on August 6, 2026.
This under-the-radar healthcare stock just made its biggest acquisition ever -- and it could easily outperform many of Wall Street's favorite names.
TARRYTOWN, N.Y., June 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige Brands”), intends to offer, subject to market and other conditions, up to $400 million in aggregate principal amount of new senior notes due 2034 (the “notes”) in a private offering. The notes will be senior unsecured…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for PBH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.